SG EFF. CALL24 LLY | Market Closed - BME 11:30:00 2024-06-27 am EDT | ||
| 0.86 EUR | -2.27% |
|
| Current month | +65.38% | ||
| 1 month | +65.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 0.86 | -2.27% |
| 24-06-26 | 0.88 | -2.22% |
| 24-06-25 | 0.9 | +5.88% |
| 24-06-24 | 0.85 | +7.59% |
| 24-06-21 | 0.79 | -9.20% |
Delayed Quote BME
Last update June 27, 2024 at 11:30 am EDT
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| K9097 | |
| ISIN | DE000SW92596 |
| Date issued | 2024-05-14 |
| Maturity | 2024-12-20 (176 Days) |
| Parity | 100 : 1 |
| Emission price | 0.36 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.9 € |
|---|---|
| Lowest since issue | 0.33 € |
| Delta | 0x |
| Omega | 0.000000 |
| Premium | 0x |
| Gearing | 9.84x |
| Moneyness | 0.000000 |
| Spread | 0.01 € |
| Spread % | 1.16% |
| Intrinsic value | 0.000000 |
| Present value | 0.8550 |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Warrants
- K9097 Warrant
